| Tag | Content |
|---|
EnhancerAtlas ID | HS182-09492 |
Organism | Homo sapiens |
Tissue/cell | Spleen |
Coordinate | chr17:44230800-44233090 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| KLF4 | MA0039.3 | chr17:44232110-44232121 | AGAGGGTGTGG | - | 6.02 | | MEF2A | MA0052.3 | chr17:44232694-44232706 | TCTATTTTTAGT | - | 6.27 | | MEF2B | MA0660.1 | chr17:44232694-44232706 | TCTATTTTTAGT | - | 6.32 | | MEF2C | MA0497.1 | chr17:44232693-44232708 | TTCTATTTTTAGTAG | - | 6.57 | | RREB1 | MA0073.1 | chr17:44232108-44232128 | TGAGAGGGTGTGGTGGGGGG | - | 6.2 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_09447 | chr17:44227156-44235841 | CD14 | | SE_11745 | chr17:44227047-44232876 | CD20 | | SE_18395 | chr17:44228662-44239531 | CD4p_CD25-_Il17-_PMAstim_Th | | SE_19758 | chr17:44230984-44235938 | CD4p_CD25-_Il17p_PMAstim_Th17 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 3 | Chromosome | Start | End |
| chr17 | 44232982 | 44233057 | | chr17 | 44232398 | 44232585 | | chr17 | 44231183 | 44232152 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I046153 | chr17 | 44231316 | 44235566 |
|
Enhancer Sequence | AGTAAATATA TAAATAAAGC CACAGAAACA TATTCCCAAA ATGTGGGCTG GAAATGAAAA 60
CAGAACAGCA TGGGATACAA AACCCCACTG GCTGTTTACA AAATGTTTCG TGTACATGAC 120
TTTTATGTAA TAGGAACAGA ACACTAGTAT AGGAAATGAA GACTACATGG AAGGGCTGGC 180
TACTTGGAGG TGACGGAGTT AAAGATTTCA TGAACCATCA AAAGACCAGG TCATTTATAC 240
ACTAGATTAT CAAACCAGAA AAAGTCTGAG TCCCCTCATT CCATTACATT TGAAGAAATG 300
AGAAGCACCA AAAAAATAAA GTATCAATAC AAAGAAGAGA GAGAAACTAA GACAATCTGA 360
CCCTGAAGGA ATCGCAATGT GGAGGGAAAA CCCAGCCCTA GGAGTTAATT GTCTAAGTCA 420
GGTAAGAAAA GAGTGAAAAA GTTGAACAGC ACAACAGACT ATTTCATGAA CACCAGATGC 480
CTCGATATGT AAGGGCTTTA AATAAAGAGA AAACACTCTC CTCATGAGCT GCTGCTTCAG 540
TGCCTAGTTC TTCACTCAAC TATACCCCCC TCTAAATCAG ATGCAGCATT TTGAAATCGA 600
CCTCACTCCC TTAACCACAC TTAATTTTTG GAGTAGAGGT TAATGAACAC ACCAGGATAA 660
AACGATGTCT AGTTTGGCAG GAGTGGGAGT ACAAAAGTAA GGGGAAAAAG ACAAGAAAGA 720
ACAAAGCACT GGTTCGCACA CCTCTCTCCA CCCCAGTTAA GCTGTGGAAA GCTGACTGGC 780
ATATCCACAT GCTTAAATTA TACGTTACTG GCAATGAGGG AAGTGGGGAA ATGCTAACAT 840
TCTGATTTGT CCCTTGACAA ATGAGGGAGG ATATTCCCCC CTCAGGGTTG CACTTTAAGA 900
ATTTCTACTT GCAATGCTCA CTGCAGCCTC GACCTCCCAG GCTCAAGTGA TCCTCCCATC 960
TCAGCTTCCC GAGTAGCTGG GACTACAGGT GTGAACCACA ACATCTAGCT CATTTCTTGT 1020
GGTTTATTGT ACAGATGGGC GTCACCACGT TGCCCAGGCT GGTCTCGAAC TCCTTGAGCT 1080
CAAGTGATCC CCCTGCCTCA GCATCCCAAA GCACTGGGAT TACAGGCCTA AGCCACCGTG 1140
CCCGGGCTCT CACCACAATT ATAAAAAGAG AGAGAATGAA GGGAAGGGTA GAATTTCCTC 1200
TTTAAAAGTG GTCTGACTCA CCAAACCATC TTCACTGCAA AGCCTTAAAC AGTACCAGAA 1260
TACAGGAAAA GGATATTGTA TGCTTTTCTT AGAGCTGGGA CAAAGAAATG AGAGGGTGTG 1320
GTGGGGGGAA GGAGTAAACA ATCAGAGCAT AAGTAACCCA TATTATACAT GGTTTATATG 1380
ATGCCATCTC CAGGTTTAAT CTTTCCCTTT TATTATTTTA TGATTATTTT AATGGAGATG 1440
GGGTCTTGCT ATGTTGACCA CACTGGCCTC AAAGTCCTGG CCTCCTAAAG TACTGGGATT 1500
ACAAGGTATA AGCCACCACG AGCAGCCTAA TCTCTCAATT TTAGTTTCCT TACCATAAAA 1560
CAGACACAAT GCTTACTATA CAATTAAAAT ATGCTATAAA ATAGTAAGTG AAATAACTAT 1620
ACTAAAAGGC ATTCCTGGCA TTCAGAAAAG TTGATGGTAG CATCCTTTCC CCCTCAAAGA 1680
TAGGTACAGG AGGCCCTAAT CCAATAGTTC TCAGCCAGGG ATTTTTTTTT TTTTTTTTTT 1740
TTTTTTGAGA TGGAGTCTTG CTCTATTGCC CAGGCTGTAG TGTTGCCATC TCGGCTCACA 1800
GCAACCTCCA CCTCCCGGGT TCAAGCGATT CTCCTGCCTC AACTTCCCAA GTAGCTGGGA 1860
CTACAGGCGT GTGCGACCAT GCCCAGCTAA TTTTTCTATT TTTAGTAGAG ACAGGATTTC 1920
GCCATGTTGG CCAGGCTGGT CTCGAACTCC CGGCCTCAAA TGATTCGCCC ACCTCGGCCT 1980
CCCAAAGTGC TGAGATTACA GGTGTGAACC GCTGCTCCCA GCCTTGGGGA TTATTTTGAC 2040
CTTACCCCAA CCCCCAAAAG GGCACATATA ATAAAGTCTG GAAAAATTTT GTTGTCTCAA 2100
CTAGGGTGAG GGAAGGTCCT ACTGGCATTT AGGGGGTAGA GGCCAGAGAC GCCATCAGGC 2160
ATTCTTACAG TGCACAGAAT AGCTTCCCAT GACAAATAAT TATTAGTCCC AAAAGGTTAA 2220
TGGTGCCTCT GTTAAGAAAA CCTGCCTAAA AAACATTCAT TTTTGGAAAA ACCACATAAA 2280
CACAGAAGAG 2290
|
